If you’re a small-business benefits admin for a team of 8 to 50 employees, it’s common to receive a request from a team member for clarity on coverage for a specialty drug used to treat a chronic condition, rare disease, or cancer. You may also be weighing plan options ahead of open enrollment and want to avoid unexpected cost spikes from high-cost specialty medications that could drive up your group’s renewal rates. This guide breaks down targeted questions to ask your insurance carrier, plan administrator, and licensed broker to clarify coverage, cost-sharing, and administrative rules for specialty drugs on your small-group plan.
Start with one decision
The first decision you need to make before reaching out to your carrier or broker is whether you are asking questions to address a current employee’s immediate specialty drug need, or evaluating specialty drug coverage as part of your upcoming plan renewal process. These two scenarios require different sets of questions, so narrowing down your goal first will help you avoid unnecessary calls and get the specific information you need faster. If you are responding to an immediate employee need, you can prioritize questions about your current plan’s existing rules and formulary. If you are evaluating renewal options, you can focus on comparing formulary coverage, cost tradeoffs, and utilization rules across multiple plan options.
If/then rules
Structure your question list based on your core goal to avoid irrelevant follow-ups:
If your goal is addressing an immediate employee need, then ask these core questions first to get answers within 3 business days of the employee’s request to avoid delays in access to their medication:
- Is the specific prescribed drug (include the drug name and National Drug Code, if provided by the employee) on your current plan’s specialty drug tier?
- What prior authorization, step therapy, or quantity limit requirements apply to this drug for the remainder of the current plan year?
- What is the employee’s per-fill cost-sharing for this drug, including any copay accumulator or maximizer programs the plan uses? Illustrative example: If a specialty drug has a list price of $6,000 per month, a plan with a 20% coinsurance requirement for specialty drugs would mean the employee pays $1,200 per fill before hitting their out-of-pocket maximum, unless they qualify for copay assistance.
- Are in-network specialty pharmacies available via home delivery, or within a reasonable distance of the employee’s home address?
If your goal is evaluating specialty drug coverage for your next plan renewal, then ask these core questions to compare plan options and avoid unexpected cost increases for your business and your team:
- What share of the most commonly prescribed specialty drugs for chronic conditions, oncology, and rare diseases are covered on each proposed plan’s formulary?
- What is the per-member per-month (PMPM) cost difference between your current base plan, and plan options with expanded specialty drug coverage?
- Does the plan allow manufacturer copay assistance funds to count toward the employee’s annual out-of-pocket maximum?
- Are lower-cost biosimilar alternatives available for covered brand-name specialty drugs on the formulary?
- What utilization management rules apply to specialty drugs for the coming plan year?
Edge cases
There are several common edge cases that require additional questions beyond the core lists above, as standard pharmacy benefit rules do not always apply:
- **Administered specialty drugs**: Many specialty drugs, including infusions or injectables administered in a provider’s office or clinic are often billed under the plan’s medical benefit, not the standard pharmacy benefit. For these drugs, ask: Is this administered specialty drug covered under the in-network provider’s medical benefit, and what cost-sharing (deductible, coinsurance, copay) applies for in-network vs out-of-network providers?
- **Non-formulary rare disease drugs**: If an employee needs a specialty drug for a rare disease that is not listed on the plan’s formulary, ask: What is the plan’s formal exception request process for non-formulary specialty drugs, and what documentation is required from the employee’s prescribing provider to submit a request?
- **Secondary plan coverage**: If an employee is covered under a spouse’s plan as their primary coverage, and uses your small-group plan as secondary, ask: Will the secondary plan cover remaining cost-sharing for a specialty drug that the primary plan only covers partially?
- **Stop-loss threshold eligibility**: Small-group plans often have aggregate stop-loss coverage that limits the total amount your business pays for covered claims in a plan year. For high-cost specialty drugs, ask: What portion of specialty drug costs count toward the plan’s stop-loss deductible, and are there any exclusions for specific specialty drug classes?
Illustrative worksheet
The below printable specialty-drug question checklist is designed to bring to your next call with your carrier or broker, so you can document all required information in one place:
| Category | Question to ask | Space for notes/answer |
|---|---|---|
| Immediate employee need | Is the specific prescribed specialty drug (list drug name/NDC if available) on the current plan formulary? | |
| Immediate employee need | What prior authorization, step therapy, or quantity limit rules apply to this drug for the current plan year? | |
| Immediate employee need | What is the employee’s per-fill cost-sharing for this drug, including any copay accumulator rules? | |
| Immediate employee need | Are in-network specialty pharmacies available via home delivery or within a reasonable distance of the employee’s home? | |
| Immediate employee need | If this drug is administered in a clinical setting, what cost-sharing applies under the plan’s medical benefit? | |
| Plan renewal evaluation | What share of the most commonly prescribed specialty drugs for chronic conditions, oncology, and rare diseases are covered on the proposed plan’s formulary? | |
| Plan renewal evaluation | What is the PMPM cost difference between plans with standard vs expanded specialty drug coverage? | |
| Plan renewal evaluation | Does the plan allow manufacturer copay assistance funds to count toward the employee’s annual out-of-pocket maximum? | |
| Plan renewal evaluation | Are lower-cost biosimilar alternatives available for covered brand-name specialty drugs? | |
| Plan renewal evaluation | What is the average turnaround time for non-formulary specialty drug exception requests for the proposed plan? | |
| Edge case (rare disease drugs) | What is the full timeline and documentation requirement for a non-formulary drug exception request? | |
| Edge case (secondary coverage) | Will this plan cover remaining cost-sharing for a specialty drug if the employee’s primary plan only covers a portion of costs? | |
| Edge case (stop loss) | Do all specialty drug costs count toward the plan’s aggregate stop-loss deductible? |
Bottom line
Specialty drugs represent a significant portion of overall small-group health plan costs, and coverage rules can vary widely between carriers and plan designs. Asking targeted, specific questions before an employee needs access to a specialty drug, or when evaluating renewal plan options, can help you avoid unexpected costs for both your business and your team members. Always cross-reference any answers you receive from your carrier with your official Summary of Benefits and Coverage (SBC) to confirm rules apply to your specific plan.
This content is for educational purposes only, and does not constitute insurance, tax, legal, or medical advice. Always verify all plan details with your official plan documents and a licensed insurance broker before making benefits decisions for your small group.
Important note: This page is educational and is not insurance, tax, legal, or medical advice. Confirm current rules in your plan documents or with a licensed professional.
